Registration Of Veterinary Pharmaceuticals In China: Registration Opens For October 22, 2026 Online Training On Navigating China's Regulatory Approval Process
Dublin, Sept. 10, 2026 (GLOBE NEWSWIRE) -- The "Registration of Veterinary Pharmaceuticals in China (Oct 22, 2026)" has been added to ResearchAndMarkets.com's offering.
Veterinary Drug Registration in China: Practical Guidance for Market Approval
China's substantial demand for veterinary drugs presents significant commercial opportunities for companies seeking to enter or expand within the market. However, achieving veterinary drug market approval in China requires careful navigation of a distinct regulatory framework, detailed registration procedures and specific compliance requirements.
This focused training course provides practical advice and regulatory guidance for organisations pursuing veterinary drug registration in China. During the programme, participants will examine the principal requirements associated with obtaining market approval and develop a clearer understanding of the regulatory considerations that can influence a successful submission.
China operates a separate regulatory system for veterinary medicinal products, making informed preparation essential for companies planning a market-entry strategy. Registration requirements may affect development planning, documentation, submission management and overall approval timelines. The course will help participants identify relevant regulatory obligations and consider how these requirements should be incorporated into their registration strategy.
Expert speakers will explain the regulations and registration procedures applicable to veterinary drugs in China through concise, structured presentations. The programme is designed to translate complex regulatory requirements into practical considerations that participants can apply when planning, preparing or supporting an application for Chinese market approval.
Key areas addressed during the course include:
- The regulatory environment for veterinary drugs in China Core requirements for veterinary drug market approval Key stages within the Chinese veterinary drug registration process Important considerations when preparing registration documentation Regulatory factors that may affect submission planning and approval Practical approaches to managing the registration process
The training will be particularly relevant to professionals involved in regulatory affairs, veterinary pharmaceutical development, product registration, compliance, market access and international business development. It may also benefit organisations evaluating the Chinese veterinary medicine market or preparing to engage with the country's regulatory approval process.
By attending, participants will gain a more comprehensive understanding of the requirements that support veterinary drug approval in China. This knowledge can assist teams in assessing regulatory expectations, coordinating internal resources and preparing more effectively for the challenges associated with a separate national registration system.
The programme also includes opportunities for participants to raise questions with the expert speakers. This interactive element allows attendees to explore issues relevant to their responsibilities and obtain additional clarification on the regulations and procedures discussed during the presentations.
As demand for veterinary medicines continues to create opportunities in China, companies require a well-informed and carefully structured approach to regulatory compliance. Early understanding of the applicable requirements can support more effective decision-making, strengthen registration planning and help organisations allocate appropriate resources throughout the market approval process.
This one-hour course offers a concise and practical introduction to veterinary drug registration in China. It is suitable for professionals seeking current, focused guidance without the time commitment of a longer training programme. Attendees will leave with an improved understanding of the Chinese veterinary drug regulatory framework and the considerations involved in progressing a product towards market approval.
Continuing Professional Development: 1 CPD hour
Who should attend
This event will be beneficial to companies interested in expanding into the Chinese markets, as well as to registration personnel responsible for market approval matters:
- New entrants to registration departments Veterinary medicinal product manufacturers Registration managers Research and development departments Academics with an interest in commercialising opportunities
Key Topics Covered:
- Day 1
- China market access and regulatory requirements for veterinary drugs (VD) Regulatory framework Registration of imported feed/feed additives in China
Speakers
Bi Jun
Bi Jun is a pharmaceutical expert with more than 10 years of experience in health product development and registration in China. Currently in Knoell Shanghai, he is mainly responsible for regulatory support and the registration of pharmaceutical ingredients and packaging materials for human drugs (DMF), Biocides, feed/feed additives and veterinary drugs.
For more information about this training visit
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment